Management of Arterial Hypertension: 2018 ACC/AHA Versus ESC Guidelines and Perioperative Implications

Alejandro Travieso-Gonzalez1, Iván J Núñez-Gil1, Hynek Riha2

  • 1Cardiology, Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.

Insights

Managing hypertension, a global cardiovascular risk, lacks uniformity despite existing guidelines. This review compares recent American and European hypertension guidelines to clarify differences for clinicians.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines
  • Public Health

Background:

  • Hypertension is a leading global cardiovascular risk factor, contributing significantly to mortality and morbidity.
  • Current evaluation and management of hypertension lack uniformity, despite numerous international society guidelines.
  • Discrepancies in expert-based recommendations within guidelines can create confusion for healthcare providers.

Purpose of the Study:

  • To compare recent updated guidelines for arterial hypertension management.
  • To highlight key differences between the American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines.
  • To provide clarity for practicing clinicians regarding hypertension management strategies.

Main Methods:

  • Comparative analysis of recent ACC/AHA and ESC/ESH hypertension management guidelines.
  • Identification and summarization of significant differences in recommendations.
  • Focus on aspects relevant to clinical practice.

Main Results:

  • The manuscript identifies and discusses critical differences in the latest ACC/AHA and ESC/ESH hypertension guidelines.
  • These differences pertain to various aspects of hypertension evaluation and management.
  • Understanding these distinctions is crucial for consistent clinical application.

Conclusions:

  • Harmonizing hypertension management requires addressing guideline discrepancies.
  • Clinicians must be aware of the differences between major international guidelines for optimal patient care.
  • Further efforts are needed to promote a more standardized global approach to hypertension management.

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
389
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
584
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
450
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
478
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
601
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
393